Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Pharmeasy to acquire diagnostics chain Thyrocare in a deal worth over Rs 6,300 crore

by AIP Online Bureau | Jun 26, 2021 | Eco/Invest/Demography, Health, Indian News, Non-Life, Technology

  Mumbai: Startup Pharmeasy on Friday announced acquiring established diagnostics chain Thyrocare Technologies in a deal worth over Rs 6,300 crore, including buying the controlling stake from its 62-year-old founder A Velumani. Pharmeasy's parent company API...

Ixigo clocks 10 lakh searches for travel bookings, 3 lakh for vaccine slots

by AIP Online Bureau | Jun 26, 2021 | Eco/Invest/Demography, Facts, Health, Non-Life, Pandemic

Travel booking app ixigo said on Friday its vaccine slot finder tool clocked over three lakh user subscriptions for slot availability notifications since the launch last month. At the same time, with second wave of Covid-19 pandemic ebbing and several states relaxing...

Novel method to accurately, quickly detect COVID-19 from phone swabs

by AIP Online Bureau | Jun 26, 2021 | Eco/Invest/Demography, Facts, Health, Non-Life, Pandemic, Technology

Researchers have developed a non-invasive and low-cost method that can accurately and rapidly detect Covid-19 using samples taken from the screens of smartphones. The researchers from University College London (UCL) in the UK analysed swabs from mobile screens rather...

Antibodies triggered by Chinese COVID-19 shots less effective on Delta variant: researcher

by AIP Online Bureau | Jun 26, 2021 | Eco/Invest/Demography, Facts, Health, Non-Life, Pandemic

Beijing: Antibodies triggered by two Chinese COVID-19 vaccines are less effective against the Delta variant compared with other strains but the shots still offer protection, a Chinese disease control researcher told state media. The Delta variant of the new...

Genetic study of liver cancer reveals new drug target

by AIP Online Bureau | Jun 26, 2021 | Eco/Invest/Demography, Facts, Health

  Washington: Drugs targeting the gene MAGEA3 may help block the growth of hepatocellular carcinoma (HCC), the most common type of primary liver cancer and one of the leading causes of cancer deaths in the country, new research found. The conclusion of the new...
« Older Entries
Next Entries »

Recent Posts

  • Govt launches live stock insurance portal
  • Wage ceiling hike to Rs 25,000 a ‘win-win situation’, more people on margin to get social protection: Labour Secretary
  • Trai mandates telcos to take action against spammers identified by their AI-based caller ID
  • SC asks Centre to examine statutory safeguards for minors on social media
  • 100% FDI in pension fund industry soon:PFRDA chairman

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy